Operating Income (Loss) in USD of Verrica Pharmaceuticals Inc. from Q1 2017 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Verrica Pharmaceuticals Inc. quarterly/annual Operating Income (Loss) history and change rate from Q1 2017 to Q3 2025.
  • Verrica Pharmaceuticals Inc. Operating Income (Loss) for the quarter ending 30 Sep 2025 was $1.63M.
  • Verrica Pharmaceuticals Inc. Operating Income (Loss) for the twelve months ending 30 Sep 2025 was -$16.4M, a 78.9% increase year-over-year.
  • Verrica Pharmaceuticals Inc. annual Operating Income (Loss) for 2024 was -$65.9M, a 0.24% decline from 2023.
  • Verrica Pharmaceuticals Inc. annual Operating Income (Loss) for 2023 was -$65.8M, a 209% decline from 2022.
  • Verrica Pharmaceuticals Inc. annual Operating Income (Loss) for 2022 was -$21.3M, a 31.1% increase from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Change (%)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Change (%)

Verrica Pharmaceuticals Inc. Quarterly Operating Income (Loss) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 -$16.4M $1.63M +$22.3M 01 Jul 2025 30 Sep 2025 10-Q 14 Nov 2025
Q2 2025 -$38.7M $1.51M +$16.7M 01 Apr 2025 30 Jun 2025 10-Q 12 Aug 2025
Q1 2025 -$55.5M -$8.13M +$10.5M +56.3% 01 Jan 2025 31 Mar 2025 10-Q 13 May 2025
Q4 2024 -$65.9M -$11.4M +$11.7M +50.7% 01 Oct 2024 31 Dec 2024 10-K 11 Mar 2025
Q3 2024 -$77.6M -$20.7M +$3.21M +13.4% 01 Jul 2024 30 Sep 2024 10-Q 14 Nov 2025
Q2 2024 -$80.9M -$15.2M -$3.59M -30.9% 01 Apr 2024 30 Jun 2024 10-Q 12 Aug 2025
Q1 2024 -$77.3M -$18.6M -$11.5M -162% 01 Jan 2024 31 Mar 2024 10-Q 13 May 2025
Q4 2023 -$65.8M -$23.1M -$16.9M -272% 01 Oct 2023 31 Dec 2023 10-K 11 Mar 2025
Q3 2023 -$48.8M -$23.9M -$25.4M -1752% 01 Jul 2023 30 Sep 2023 10-Q 05 Nov 2024
Q2 2023 -$23.5M -$11.6M -$2.5M -27.4% 01 Apr 2023 30 Jun 2023 10-Q 14 Aug 2024
Q1 2023 -$21M -$7.09M +$321K +4.33% 01 Jan 2023 31 Mar 2023 10-Q 13 May 2024
Q4 2022 -$21.3M -$6.21M +$2.26M +26.6% 01 Oct 2022 31 Dec 2022 10-K 29 Feb 2024
Q3 2022 -$23.6M $1.45M +$13.2M 01 Jul 2022 30 Sep 2022 10-Q 09 Nov 2023
Q2 2022 -$36.8M -$9.12M +$1.61M +15% 01 Apr 2022 30 Jun 2022 10-Q 08 Aug 2023
Q1 2022 -$38.4M -$7.41M -$7.47M -12450% 01 Jan 2022 31 Mar 2022 10-Q 09 May 2023
Q4 2021 -$30.9M -$8.47M +$3.56M +29.6% 01 Oct 2021 31 Dec 2021 10-K 06 Mar 2023
Q3 2021 -$34.5M -$11.8M -$2.13M -22.1% 01 Jul 2021 30 Sep 2021 10-Q 07 Nov 2022
Q2 2021 -$32.3M -$10.7M -$2.1M -24.3% 01 Apr 2021 30 Jun 2021 10-Q 11 Aug 2022
Q1 2021 -$30.2M $60K +$9.94M 01 Jan 2021 31 Mar 2021 10-Q 09 May 2022
Q4 2020 -$40.2M -$12M -$4.04M -50.6% 01 Oct 2020 31 Dec 2020 10-K 02 Mar 2022
Q3 2020 -$36.1M -$9.64M -$3.09M -47.3% 01 Jul 2020 30 Sep 2020 10-Q 12 Nov 2021
Q2 2020 -$33M -$8.63M -$1.11M -14.8% 01 Apr 2020 30 Jun 2020 10-Q 10 Aug 2021
Q1 2020 -$31.9M -$9.88M -$1.85M -23.1% 01 Jan 2020 31 Mar 2020 10-Q 07 May 2021
Q4 2019 -$30.1M -$7.99M +$198K +2.42% 01 Oct 2019 31 Dec 2019 10-K 13 Mar 2020
Q3 2019 -$30.3M -$6.54M -$211K -3.33% 01 Jul 2019 30 Sep 2019 10-Q 09 Nov 2020
Q2 2019 -$30.1M -$7.52M -$2.05M -37.5% 01 Apr 2019 30 Jun 2019 10-Q 05 Aug 2020
Q1 2019 -$28M -$8.03M -$6.14M -325% 01 Jan 2019 31 Mar 2019 10-Q 07 May 2020
Q4 2018 -$21.9M -$8.19M -$6.75M -471% 01 Oct 2018 31 Dec 2018 10-K 13 Mar 2020
Q3 2018 -$15.1M -$6.33M -$4.97M -366% 01 Jul 2018 30 Sep 2018 10-K 13 Mar 2020
Q2 2018 -$10.2M -$5.47M -$4.38M -400% 01 Apr 2018 30 Jun 2018 10-K 13 Mar 2020
Q1 2018 -$5.78M -$1.89M -$1.32M -231% 01 Jan 2018 31 Mar 2018 10-K 13 Mar 2020
Q4 2017 -$4.46M -$1.43M 01 Oct 2017 31 Dec 2017 10-K 07 Mar 2019
Q3 2017 -$1.36M 01 Jul 2017 30 Sep 2017 10-K 07 Mar 2019
Q2 2017 -$1.1M 01 Apr 2017 30 Jun 2017 10-K 07 Mar 2019
Q1 2017 -$570K 01 Jan 2017 31 Mar 2017 10-K 07 Mar 2019

Verrica Pharmaceuticals Inc. Annual Operating Income (Loss) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$65.9M -$160K -0.24% 01 Jan 2024 31 Dec 2024 10-K 11 Mar 2025
2023 -$65.8M -$44.5M -209% 01 Jan 2023 31 Dec 2023 10-K 11 Mar 2025
2022 -$21.3M +$9.61M +31.1% 01 Jan 2022 31 Dec 2022 10-K 29 Feb 2024
2021 -$30.9M +$9.27M +23.1% 01 Jan 2021 31 Dec 2021 10-K 06 Mar 2023
2020 -$40.2M -$10.1M -33.6% 01 Jan 2020 31 Dec 2020 10-K 02 Mar 2022
2019 -$30.1M -$8.2M -37.5% 01 Jan 2019 31 Dec 2019 10-K 17 Mar 2021
2018 -$21.9M -$17.4M -391% 01 Jan 2018 31 Dec 2018 10-K 13 Mar 2020
2017 -$4.46M 01 Jan 2017 31 Dec 2017 10-K 07 Mar 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.